Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > I might be wrong GUY's but I smell a small--PP.--at 0.30--

<< Previous

Bullboard Posts

Next >>

Comment by CancerSlayeron Aug 30, 2022 10:52am

258 Views

Post# 34929529

RE:RE:RE:I might be wrong GUY's but I smell a small--PP.--at 0.30--

skys1 wrote: Guys, management has told us several times they had enough cash to last through the Ph 2 trials. Why won't you believe them? If I felt I could not believe the management of a compasny I held stock in, I would sell it.

To believe or not to believe, it's hard to sell good science. Having said that, TLT has performed admirably overall considering the relatively little amount of money it has required to get us this far. JMO.

<< Previous

Bullboard Posts

Next >>

Half of Canadians considering housing outside of large urban centres